Hims & Hers Health, Inc. — Form 8-K Summary
Business context and reporting period
Hims & Hers Health, Inc. filed this Form 8-K on November 6, 2023 under Item 2.02 to announce results of operations for the quarter ended September 30, 2023. The filing furnishes, rather than files, the related press release as Exhibit 99.1.
Financial results and condition
The filing text provided does not include the press release or a clear value for revenue, net income or loss, cash flow, margins, debt, liquidity, subscribers, or other financial metrics.
Material changes versus the prior comparable period
The filing text does not provide sufficient financial information to assess changes versus the prior-year quarter or another comparable period.
Guidance, outlook, risks, and unusual items
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the filing text provided. These matters may be included in the referenced Exhibit 99.1 press release, which is not reproduced here.
Key facts for investors to verify
- Obtain and review Exhibit 99.1 for the complete quarterly results and management commentary.
- Verify revenue, profitability, adjusted EBITDA, operating cash flow, free cash flow, and margin figures for the quarter ended September 30, 2023.
- Verify liquidity, cash and equivalents, debt, subscriber or membership metrics, and year-over-year changes.
- Review any updated full-year or next-quarter guidance and the assumptions supporting it.
- Note that the Form 8-K and Exhibit 99.1 were furnished pursuant to Item 2.02 and are not deemed filed for purposes of Section 18 liability except as expressly incorporated by reference.